U.S. Federal Antitrust Agencies have announced a new cooperation initiative with labor agencies aimed at enhancing scrutiny during merger reviews. This initiative comes amid increasing concerns about how mergers impact labor markets. The announcement follows a public meeting held by the Interagency Strike Force on Unfair and Illegal Pricing, which is part of a broader effort to address antitrust issues. Additionally, the Federal Trade Commission (FTC) is intensifying its focus on competition within pharmaceutical markets and is supporting FDA guidance regarding biosimilars. The FDA is also promoting pre-approval processes for changes to medical devices and laboratory-developed tests, further indicating a comprehensive approach to regulatory oversight in various sectors, including consumer protection and employment law.